Nanophotonic biosensors for point-of-care COVID-19 diagnostics and coronavirus surveillance
Gisela Ruiz‐Vega, Maria Soler, Laura M. Lechuga
Abstract
Abstract The COVID-19 pandemic has revealed the need of novel diagnostic technologies for rapid and accurate virus detection. In the European CONVAT project, a point-of-care nanophotonic biosensor is being developed for the direct, fast and specific identification of severe acute respiratory syndrome coronavirus 2 from both human patient samples and animal reservoirs. The technology will provide a quantitative detection of the viral load and it can be implemented in decentralized settings to improve the early diagnosis and clinical management of patients as well as coronavirus environmental monitoring to prevent future outbreaks.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicOutbreakCoronavirusPoint of careSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Identification (biology)NanophotonicsPoint-of-care testing2019-20 coronavirus outbreakVirologyComputer scienceMedicineNanotechnologyBiologyImmunologyInfectious disease (medical specialty)DiseasePathologyMaterials scienceBotanySARS-CoV-2 detection and testingBiosensors and Analytical DetectionAdvanced biosensing and bioanalysis techniques